polatuzumab vedotin (Polivy) Report issue

Biologics mAb ADC Orphan Drug FDA Approved FDA First in Class Accelerated Approval FDA

Back

Chemistry

Mol. Mass

Missing data

ALogP

Missing data

Rule of 5

Missing data

Rule of 3

Missing data
Details

Sources

CHEMBL2109272   ChEMBL

CHEMBL2109278   ChEMBL

CHEMBL3301582   ChEMBL
polatuzumab vedotin

CHEMBL3301585   ChEMBL
pinatuzumab vedotin

KG6VO684Z6   NCATS
polatuzumab vedotin *

Polatuzumab vedotin   Wikipedia

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue